SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-001677
Filing Date
2024-11-12
Accepted
2024-11-12 08:05:34
Documents
47
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q artl_10q.htm   iXBRL 10-Q 979327
2 CERTIFICATION artl_ex311.htm EX-31.1 9374
3 CERTIFICATION artl_ex321.htm EX-32.1 3544
  Complete submission text file 0001640334-24-001677.txt   3667610

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20240930.xsd EX-101.SCH 31733
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20240930_lab.xml EX-101.LAB 208415
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20240930_cal.xml EX-101.CAL 32481
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20240930_pre.xml EX-101.PRE 173515
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20240930_def.xml EX-101.DEF 95670
50 EXTRACTED XBRL INSTANCE DOCUMENT artl_10q_htm.xml XML 456507
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

IRS No.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38951 | Film No.: 241443555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)